Congenital antithrombin deficiency type 2
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
|Generic Name||Recombinant human antithrombin|
(GTC Biotherapeutics, Inc.)
The FDA has approved this product to be used in this manner.
|Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.|
|More Information about this product||Drug Information Portal|